Has Samita Goyal, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,256 in general payments to Samita Goyal, MD across 159 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Samita Goyal, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Samita Goyal, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Samita Goyal, MD

Plastic and Reconstructive Surgery · Glen Allen, VANPI 1043577190

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (45.2%), travel and lodging and other — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Integra Lifesciences Corporation at 33.2% of the total. 2025 is the largest year on record at $4,493, more than ten times the $263 reported in 2019. Among plastic and reconstructive surgery clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,256in general payments, 2019–2025

Across 159 payments — averaging $83.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Integra Lifesciences Corporation$4K
Axogen$3K
Musculoskeletal Transplant Foundation Inc.$2K
Mentor Worldwide LLC$1K
Biotissue Holdings Inc.$1K
TELA Bio, Inc.$212
plus $1K from 10 others

What the payments were for

Consulting fees$1,50011%
Travel & lodging$3,43826%
Food & beverage$5,98945%
Other$2,32918%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Integra Lifesciences Corporation	26	$4,401
Axogen	11	$2,835
Musculoskeletal Transplant Foundation Inc.	40	$2,461
Mentor Worldwide LLC	45	$1,156
Biotissue Holdings Inc.	3	$1,147
TELA Bio, Inc.	4	$212
Motiva USA, LLC	15	$209
Sientra, Inc.	2	$206
AbbVie(2 entities)	3	$184
Davol Inc.	3	$149
Baxter Healthcare	2	$130
Johnson & Johnson	1	$60
Checkpoint Surgical, Inc	1	$57
Galderma Laboratories, L.p.	1	$20
Sanara Medtech Inc.	1	$14
Smith+Nephew	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTEGRA$3,000
AVANCE NERVE GRAFT$2,659
AxoGuard Nerve Connector$2,659
AxoGuard Nerve Protector$2,659
AXOGUARD HA+ NERVE PROTECTOR$2,659
AxoGuard Nerve Cap$2,659
DuraSorb Monofilament Mesh$2,449
Prokera$1,072
AmnioGraft$1,072
AmnioGuard$1,072
NATRELLE$148
SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$147
OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$100
MENTOR MemoryGel Resterilizable Gel Sizer$100

How this compares

$13,256 in reported general payments places this provider in the 90th percentile of 77 plastic and reconstructive surgery providers in Virginia.

See all plastic and reconstructive surgery providers in Virginia →

Medicare billing

Part B allowed, 2024

$14,504

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	14	$198
Oxycodone Hcl	18	$98
Montelukast Sodium	16	$97

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Glen Allen

Maurice NahabedianMc Lean$828K
Mark VenturiMc Lean$356K
Neil ZemmelRichmond$38K
Lauren NigroRichmond$28K
Burton SundinRichmond$23K
Vinod ChopraChantilly$19K
Alexander SailonVirginia Beach$19K
Alexandra TiltVirginia Beach$13K
Victoria VastineCharlottesville$12K
Robert SchnarrsNorfolk$10K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →